Celsion Corporation to Hold Year-End 2019 Financial Results Conference Call on Thursday, March 26, 2020
March 19, 2020 08:30 ET
|
Celsion CORP
Company to Provide Update on its Phase III OPTIMA Study in Primary Liver Cancer and its Phase I/II OVATION 2 Study in Ovarian Cancer LAWRENCEVILLE, N.J., March 19, 2020 (GLOBE NEWSWIRE) -- Celsion...
Celsion Reports Unanimous Independent Data Monitoring Committee Recommendation to Continue the Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
November 04, 2019 08:00 ET
|
Celsion CORP
The Data Monitoring Committee Signals that Patient Safety Data and Data Quality Meets Expectations and Company is to Proceed to Next Interim Analysis.The Pooled Progression-Free Survival (PFS) Data is...
Celsion Corporation to Hold First Quarter 2019 Financial Results Conference Call on Wednesday, May 15, 2019
April 12, 2019 08:00 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., April 12, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter...
New “Multi-Omic” Research Projects Launched to Confront the Complexity of Glioblastoma and Pediatric Brain Tumor Treatment Development
November 08, 2018 14:25 ET
|
National Brain Tumor Society
Bethesda, MD, Nov. 08, 2018 (GLOBE NEWSWIRE) -- This week, the National Cancer Institute (NCI), the U.S. government's principal agency for cancer research, announced funding for new adult and...
Former UnitedHealth Group Cancer Director Dr. Lee Newcomer Joins Cellworks Board of Directors
October 17, 2018 08:00 ET
|
Cellworks Group, Inc.
Leading Precision Medicine Company Adds to Prestigious Board of Directors, which includes Dr. David Lawrence, Dr. Allen Lichter and Dr. Bill Rutter SAN JOSE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE)...
Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 03, 2018 17:15 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that on September 28, 2018, the Compensation...
MMRGlobal Files Additional Cancer Fighting Patent in China Under Expedited Patent Allowance Program
August 19, 2013 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 19, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...